Healthcare provider profile · identity verified

Pamela G. Smith, M.D.

Internal Medicine · GRETNA, VA · NPI 1609873009

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	725	206
Atorvastatin Calcium	Atorvastatin Calcium	684	204
Losartan Potassium	Losartan Potassium	420	123
Omeprazole	Omeprazole	419	115
Lisinopril	Lisinopril	392	120
Levothyroxine Sodium	Levothyroxine Sodium	362	96
Metformin Hcl	Metformin Hcl	333	92
Hydrochlorothiazide	Hydrochlorothiazide	301	92
Furosemide	Furosemide	276	87
Rosuvastatin Calcium	Rosuvastatin Calcium	248	75
Sertraline Hcl	Sertraline Hcl	238	64
Pantoprazole Sodium	Pantoprazole Sodium	230	73
Eliquis	Apixaban	207	43
Simvastatin	Simvastatin	206	54
Gabapentin	Gabapentin	197	51
Metoprolol Succinate	Metoprolol Succinate	197	55
Metoprolol Tartrate	Metoprolol Tartrate	191	47
Albuterol Sulfate Hfa	Albuterol Sulfate	162	63
Montelukast Sodium	Montelukast Sodium	161	51
Fluticasone Propionate	Fluticasone Propionate	159	48
Pravastatin Sodium	Pravastatin Sodium	155	47
Carvedilol	Carvedilol	149	45
Allopurinol	Allopurinol	133	38
Atenolol	Atenolol	124	35
Glimepiride	Glimepiride	123	33
Trulicity	Dulaglutide	123	15
Tamsulosin Hcl	Tamsulosin Hcl	116	40
Glipizide	Glipizide	111	34
Metformin Hcl Er	Metformin Hcl	111	36
Lovastatin	Lovastatin	108	31
Potassium Chloride	Potassium Chloride	104	33
Trazodone Hcl	Trazodone Hcl	104	30
Escitalopram Oxalate	Escitalopram Oxalate	103	32
Clopidogrel	Clopidogrel Bisulfate	93	30
Duloxetine Hcl	Duloxetine Hcl	93	28
Famotidine	Famotidine	93	32
Benazepril Hcl	Benazepril Hcl	91	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	24
Tramadol Hcl	Tramadol Hcl	78	16
Alprazolam	Alprazolam	76	14
Januvia	Sitagliptin Phosphate	76	19
Meloxicam	Meloxicam	71	22
Ezetimibe	Ezetimibe	68	23
Ozempic	Semaglutide	68	suppressed
Cephalexin	Cephalexin	67	52
Mirtazapine	Mirtazapine	67	28
Alendronate Sodium	Alendronate Sodium	66	20
Buspirone Hcl	Buspirone Hcl	65	19
Irbesartan	Irbesartan	62	18
Diclofenac Sodium	Diclofenac Sodium	60	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	23
Esomeprazole Magnesium	Esomeprazole Magnesium	58	19
Lorazepam	Lorazepam	56	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	19
Venlafaxine Hcl Er	Venlafaxine Hcl	56	13
Donepezil Hcl	Donepezil Hcl	53	20
Farxiga	Dapagliflozin Propanediol	51	14
Synthroid	Levothyroxine Sodium	50	14
Quetiapine Fumarate	Quetiapine Fumarate	49	15
Triamcinolone Acetonide	Triamcinolone Acetonide	49	27
Xarelto	Rivaroxaban	49	12
Citalopram Hbr	Citalopram Hydrobromide	48	15
Hydralazine Hcl	Hydralazine Hcl	47	18
Bupropion Xl	Bupropion Hcl	45	13
Azithromycin	Azithromycin	44	40
Spironolactone	Spironolactone	43	17
Entresto	Sacubitril/Valsartan	42	suppressed
Prednisone	Prednisone	42	30
Baclofen	Baclofen	41	17
Clonazepam	Clonazepam	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	12
Finasteride	Finasteride	38	13
Oxybutynin Chloride Er	Oxybutynin Chloride	38	16
Olmesartan Medoxomil	Olmesartan Medoxomil	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	36	11
Jardiance	Empagliflozin	34	12
Meclizine Hcl	Meclizine Hcl	34	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	32
Pioglitazone Hcl	Pioglitazone Hcl	33	11
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	26
Warfarin Sodium	Warfarin Sodium	31	11
Propranolol Hcl	Propranolol Hcl	30	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	11
Methimazole	Methimazole	27	suppressed
Ondansetron Odt	Ondansetron	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	18
Glipizide Er	Glipizide	25	suppressed
Methylprednisolone	Methylprednisolone	25	23
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Nystatin	Nystatin	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Torsemide	Torsemide	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Valsartan	Valsartan	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Primidone	Primidone	18	suppressed
Topiramate	Topiramate	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Trandolapril	Trandolapril	17	suppressed
Naproxen	Naproxen	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	11
Amoxicillin	Amoxicillin	14	14
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Fluconazole	Fluconazole	13	13
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error